Should you buy Nutex Health (NUTX)?
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
NUTX currently trades below the base anchor, in the lower half of the engine methodology range.
Engine methodology range — mechanically derived from pipeline gate outputs + peer-multiple inputs. Not an analyst price target. JSON-LD emission gated pending counsel review.
What the engine is tracking
- High Quality Roe Cash Conversion→Stable
- Thin Upside Asymmetry Failure→Stable
- Earnings Beat Streak Catalyst↑Improving
- +2 more pillars — see the Why tab for full reasoning
→ Full pillar scorecard with all 5 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1High Quality Roe Cash Conversion
Trip ifROE falls below 25% or the Piotroski F-Score drops below 6 for 2 consecutive quarters.
- P2Thin Upside Asymmetry Failure
Trip ifAsymmetry ratio stays below 1.0 for 2 consecutive quarters as the price continues to compress toward its take-profit target.
- P3Earnings Beat Streak Catalyst
Trip ifEPS surprise falls below 0% at the 2026-07-30 report, adding a second miss within the last 5 quarters.
- P4Overbought Technical Setup Near Highs
Trip ifRSI stays above 80 while price falls more than 10% from the current level within 1 quarter.
- P5High Short Interest Squeeze Setup
Trip ifShort interest rises above 30% of float while price momentum turns negative for 2 consecutive months.
How the engine reached this verdict
TrendMatrix's engine output for Nutex Health Inc. (NUTX) is STRONG_BUY_WAIT with medium conviction, score 5.9/10 at $212.63. The C-path quality+value combination cleared its gates — quality 8.4 and value 8.8 — with 1.51 asymmetric R:R supporting the read.
The engine's suggested entry zone is $202.07, currently 5.2% above entry. Target $257.66, stop $187.93, asymmetric R:R 1.51. The WAIT designation reflects entry-discipline framing — chasing into the current zone compresses asymmetry, which is why the engine separates WAIT from NOW. The engine's sizing output: 1.4% of portfolio at this asymmetry level (high-conviction tier).
On the bull side: V7 flight-to-quality bonus: +0.5 (Q=8.4 in RISK_OFF); Sector modifier (Healthcare): +0.5; Strong earnings beat streak (3/4). On the bear side: Concentration risk — Counterparty: HaloMD (exclusive IDR claims processor); Earnings in 7 days (event risk); Weak growth. Active engine warnings: V9 Gate blocked BUY_NOW: Earnings in 7 days (≤7d hard window), V9 Gate Failed: EARNINGS_PROXIMITY:7d<=7d.
BUY_NOW requires earnings proximity (7d<=7d) to clear OR price pulling back to the entry zone of $202.07 with asymmetry crossing 2.5. The verdict flips to HOLD if overall score deteriorates by ~0.7 from sentiment or technical drift.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates NUTX — 10-dimension breakdown →
Bull case
- ▸V7 flight-to-quality bonus: +0.5 (Q=8.4 in RISK_OFF)
- ▸Sector modifier (Healthcare): +0.5
- ▸Strong earnings beat streak (3/4)
Bear case
- ▸Concentration risk — Counterparty: HaloMD (exclusive IDR claims processor)
- ▸Earnings in 7 days (event risk)
- ▸Weak growth